CF CF Industries

Q1 2025 10-Q
Filed: May 8, 2025Period ending Mar 31, 2025
Health Care
Agricultural ChemicalsSEC EDGAR

CF Industries (CF) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on May 8, 2025 for the fiscal period ending Mar 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q1 2025 10-Q

Management Discussion & Analysis

  • No quarterly revenue or YoY change data disclosed in this section
  • No profitability or margin figures provided
+3 more insights

Risk Factors

  • New risk: Funding capital expenditures for Blue Point joint venture may exceed current estimates due to project scale and joint venture complexities
  • Most material update: Risks tied to construction and operation of low-carbon ammonia production facility at Blue Point, including tech performance and carbon capture challenges
+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$1.7B

+13.1% YoY

Net Income

$312M

+60.8% YoY

Gross Margin

34.4%

+657bp YoY

Operating Margin

27.4%

+675bp YoY

Net Margin

18.8%

+556bp YoY

EPS (Diluted)

$1.85

+79.6% YoY

Operating Cash Flow

$586M

+31.7% YoY

Source: XBRL data from CF Industries Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other CF Industries Quarterly Reports

Get deeper insights on CF Industries

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.